Literature DB >> 18599551

Stimulation of N-terminal truncated isoform of androgen receptor stabilizes human ether-á-go-go-related gene-encoded potassium channel protein via activation of extracellular signal regulated kinase 1/2.

Zhi-Yuan Wu1, Kun Chen, Bernard Haendler, Thomas V McDonald, Jin-Song Bian.   

Abstract

Proarrhythmic drugs induce long QT syndrome more frequently in women than men. The present study was designed to determine whether androgens regulate the function and expression of the human ether-á-go-go-related gene (HERG) encoded K+ channel, which is largely responsible for determining the QT interval. In a concentration-dependent manner (10(-9) to 10(-6) M for 24 h), 5alpha-dihydrotestosterone (5alpha-DHT) increased HERG protein abundance in HEK293 cells stably expressing HERG in the presence of coexpressed cardiac androgen receptor (AR) variant [N-terminal truncated isoform of AR (AR45)]. The elevation of HERG protein was seen in endoplasmic reticulum, Golgi, and plasma membrane without clear preferential colocalization. Coexpression of the more common form of the AR did not confer 5alpha-DHT augmentation of HERG protein. Proteasome inhibitors, N-acetyl-L-leucyl-L-leucyl-L-norleucinal and MG132 prevented the 5alpha-DHT- dependent enhancement of HERG, as did the lysosome inhibitor, bafilomycin A1. Consistently, the cycloheximide-based protein chase study showed that 5alpha-DHT prolonged HERG protein half-life. 5alpha-DHT/AR45 signaling induced phosphorylation of ERK1/2. Blockade of ERK1/2 with PD98059 and U0126 prevented the effect of androgen on HERG protein abundance. Functional studies showed that 5alpha-DHT treatment for 24 h increased HERG K+ current density in Chinese hamster ovary cells cotransfected with cDNAs of AR45 and HERG channels. Moreover, 5alpha-DHT also increased ether-á-go-go-related gene-encoded K+ channel protein abundance in isolated rabbit cardiac myocytes. In conclusion, these data provide evidence that stimulation of AR45 receptors by androgens up-regulates HERG K+ channel abundance and activity mainly through stabilizing HERG protein in an ERK1/2 dependent mechanism, and suggest a mechanism to explain the sex difference in the long QT syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18599551      PMCID: PMC5398425          DOI: 10.1210/en.2007-1802

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  46 in total

1.  Testosterone activates mitogen-activated protein kinase via Src kinase and the epidermal growth factor receptor in sertoli cells.

Authors:  Jing Cheng; Simon C Watkins; William H Walker
Journal:  Endocrinology       Date:  2007-02-01       Impact factor: 4.736

Review 2.  Androgen production in women.

Authors:  Henry G Burger
Journal:  Fertil Steril       Date:  2002-04       Impact factor: 7.329

3.  Degradation of trafficking-defective long QT syndrome type II mutant channels by the ubiquitin-proteasome pathway.

Authors:  Qiuming Gong; David R Keeney; Maurizio Molinari; Zhengfeng Zhou
Journal:  J Biol Chem       Date:  2005-03-10       Impact factor: 5.157

4.  Androgen stimulates mitogen-activated protein kinase in human breast cancer cells.

Authors:  X Zhu; H Li; J P Liu; J W Funder
Journal:  Mol Cell Endocrinol       Date:  1999-06-25       Impact factor: 4.102

5.  Ras promotes p21(Waf1/Cip1) protein stability via a cyclin D1-imposed block in proteasome-mediated degradation.

Authors:  Mathew L Coleman; Christopher J Marshall; Michael F Olson
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

6.  Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues.

Authors:  N Kimura; A Mizokami; T Oonuma; H Sasano; H Nagura
Journal:  J Histochem Cytochem       Date:  1993-05       Impact factor: 2.479

7.  The heart is a target organ for androgen.

Authors:  H C McGill; V C Anselmo; J M Buchanan; P J Sheridan
Journal:  Science       Date:  1980-02-15       Impact factor: 47.728

8.  Sex differences in the evolution of the electrocardiographic QT interval with age.

Authors:  P M Rautaharju; S H Zhou; S Wong; H P Calhoun; G S Berenson; R Prineas; A Davignon
Journal:  Can J Cardiol       Date:  1992-09       Impact factor: 5.223

9.  In vivo androgen treatment shortens the QT interval and increases the densities of inward and delayed rectifier potassium currents in orchiectomized male rabbits.

Authors:  Xiao-Ke Liu; Alexander Katchman; Bernard H Whitfield; Grace Wan; Einsley M Janowski; Raymond L Woosley; Steven N Ebert
Journal:  Cardiovasc Res       Date:  2003-01       Impact factor: 10.787

10.  Expression of estrogen receptor ESR1 and its 46-kDa variant in the gubernaculum testis.

Authors:  Christophe Staub; Michel Rauch; François Ferrière; Mélanie Trépos; Isabelle Dorval-Coiffec; Philippa T Saunders; Gilda Cobellis; Gilles Flouriot; Christian Saligaut; Bernard Jégou
Journal:  Biol Reprod       Date:  2005-06-08       Impact factor: 4.285

View more
  9 in total

1.  Wnt signaling in castration-resistant prostate cancer: implications for therapy.

Authors:  Noriko N Yokoyama; Shujuan Shao; Bang H Hoang; Dan Mercola; Xiaolin Zi
Journal:  Am J Clin Exp Urol       Date:  2014-04-15

Review 2.  Molecular Pathophysiology of Congenital Long QT Syndrome.

Authors:  M S Bohnen; G Peng; S H Robey; C Terrenoire; V Iyer; K J Sampson; R S Kass
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

Review 3.  Alternatively spliced androgen receptor variants.

Authors:  Scott M Dehm; Donald J Tindall
Journal:  Endocr Relat Cancer       Date:  2011-09-20       Impact factor: 5.678

4.  Progesterone impairs human ether-a-go-go-related gene (HERG) trafficking by disruption of intracellular cholesterol homeostasis.

Authors:  Zhi-Yuan Wu; De-Jie Yu; Tuck Wah Soong; Gavin S Dawe; Jin-Song Bian
Journal:  J Biol Chem       Date:  2011-04-27       Impact factor: 5.157

Review 5.  N-terminal truncations in sex steroid receptors and rapid steroid actions.

Authors:  Derek A Schreihofer; Phong Duong; Rebecca L Cunningham
Journal:  Steroids       Date:  2017-11-10       Impact factor: 2.668

6.  Trafficking defect and proteasomal degradation contribute to the phenotype of a novel KCNH2 long QT syndrome mutation.

Authors:  Anton Mihic; Vijay S Chauhan; Xiaodong Gao; Gavin Y Oudit; Robert G Tsushima
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

7.  Schizophrenia-Associated hERG channel Kv11.1-3.1 Exhibits a Unique Trafficking Deficit that is Rescued Through Proteasome Inhibition for High Throughput Screening.

Authors:  Nicholas E Calcaterra; Daniel J Hoeppner; Huijun Wei; Andrew E Jaffe; Brady J Maher; James C Barrow
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

8.  Gender-based differences in cardiac diseases.

Authors:  Pei-Chi Yang; Colleen E Clancy
Journal:  J Biomed Res       Date:  2011-03

9.  Presence of Androgen Receptor Variant in Neuronal Lipid Rafts.

Authors:  Jo Garza-Contreras; Phong Duong; Brina D Snyder; Derek A Schreihofer; Rebecca L Cunningham
Journal:  eNeuro       Date:  2017-08-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.